Themis Medicare Ltd's Q4FY25 Quarter Results
- 21 May 2025
Result Summary
- Themis Medicare Ltd reported a 4.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 19.1%.
- Its expenses for the quarter were up by 3.5% QoQ and 24.8% YoY.
- The net profit increased 1176.9% QoQ and decreased 21.0% YoY.
- The earnings per share (EPS) of Themis Medicare Ltd stood at 0.7 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 98.92 | 94.83 | 83.05 | 4.3% | 19.1% |
Total Expenses | 93.74 | 90.61 | 75.13 | 3.5% | 24.8% |
Profit Before Tax | 5.18 | 4.22 | 7.92 | 22.7% | -34.6% |
Tax | 2.11 | 1.14 | 1.89 | 85.1% | 11.6% |
Profit After Tax | 6.64 | 0.52 | 8.41 | 1176.9% | -21.0% |
Earnings Per Share | 0.70 | 0.10 | 9.10 | 600.0% | -92.3% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Themis Medicare Ltd is a pharmaceutical company engaged in the development, manufacture, and marketing of a wide range of pharmaceutical products. The company primarily operates in the healthcare and pharmaceutical industry, providing a variety of products, including Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). As of October 2023, there are no specific recent major developments publicly available for Themis Medicare Ltd. The company is known for its focus on high-quality standards and innovative solutions in the pharmaceutical sector.
Revenue
During Q4FY25, Themis Medicare Ltd reported a total income of ₹98.92 crores, which reflects a quarter-on-quarter (QoQ) increase of 4.3% from ₹94.83 crores in Q3FY25. Year-over-year (YoY), there was a significant increase of 19.1% from ₹83.05 crores in Q4FY24. This growth in total income reflects the company's operational progress over the past year. The increase in revenue from both the previous quarter and the same quarter last year highlights a consistent upward trend in the company's financial performance.
Profitability
In Q4FY25, Themis Medicare Ltd recorded a profit before tax (PBT) of ₹5.18 crores, which is an increase of 22.7% from the ₹4.22 crores reported in Q3FY25. However, when compared to Q4FY24, there is a decrease of 34.6% from ₹7.92 crores. The tax expense for Q4FY25 stands at ₹2.11 crores, which is substantially higher than the ₹1.14 crores in the preceding quarter, marking an 85.1% QoQ rise. YoY, the tax has increased by 11.6% from ₹1.89 crores. The profit after tax for Q4FY25 is ₹6.64 crores, a significant QoQ increase of 1176.9% from ₹0.52 crores in Q3FY25. However, YoY, there is a 21.0% decrease from ₹8.41 crores. Earnings per share (EPS) for Q4FY25 is ₹0.70, showing a dramatic increase of 600.0% from ₹0.10 in the previous quarter but a decrease of 92.3% from ₹9.10 in the same quarter last year.
Operating Metrics
During Q4FY25, Themis Medicare Ltd reported total expenses of ₹93.74 crores, which is an increase of 3.5% from Q3FY25's ₹90.61 crores. This also represents a 24.8% increase from ₹75.13 crores in Q4FY24, indicating a rise in operational costs both quarterly and annually. The company's growth in total income outpaced the increase in total expenses on a QoQ basis, while the YoY comparison shows a more substantial increase in expenses compared to income. This data provides insight into the company's operational efficiency and cost management over the quarter and year.